Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 318154 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $442.36 · Day +4.02% · Mkt cap $229.9B · P/E (FY) 29.9× · 1Y +54.2% · Off 52W high −0.2% · Vol (1Y) 27.3% Price2023-08-21 → 2026-08-19 AMGN close: $261 on 2023-08-21 to $442 on 2026-08-19. Split-adj closes · 240 of 6,694 · price returnⓘ At a glance | Short interest2.5% of sh out | | Days to cover5.2d | | 13F net flow (QoQ)−0.34% | | Top-10 13F concentration50.6% | | Next report (est.)2026-11-03 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | P/E (FY)29.9× | | Sales (TTM)$38.09B | | Earnings (TTM)$8.74B | | ROE106.1% | | Net margin21.0% | | ROIC14.4% | | Debt / equity6.31× | | Total debt / EBITDA3.83× | | EPS growth 3Y5.5% | | Sales growth 3Y11.8% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+37.1% | | 1Y+54.2% | | 3Y+84.6% | | 5Y+129.0% | | 10Y+243.9% | | Since incept. (ann.)+9.3% |
Total return · from 2000-01-03ⓘ Risk | Ann. volatility (1Y)27.3% | | Ann. volatility (3Y)26.2% | | Sharpe (1Y)1.78 | | Sharpe (3Y)0.91 | | Max drawdown (1Y)−16.6% | | Max drawdown (3Y)−22.7% | | Beta (3Y vs SPY)0.05 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| BlackRock, Inc. | 47.1M | $16.6B | 8.74% | −0.6% | | VANGUARD CAPITAL MANAGEMENT LLC | 35.0M | $12.3B | 6.50% | new | | STATE STREET CORP | 30.5M | $10.7B | 5.67% | −0.1% | | Capital World Investors | 29.3M | $10.3B | 5.43% | +26.8% | | MORGAN STANLEY | 15.8M | $5.6B | 2.94% | +0.6% | | GEODE CAPITAL MANAGEMENT, LLC | 15.4M | $5.4B | 2.86% | +7.9% | | VANGUARD PORTFOLIO MANAGEMENT LLC | 14.6M | $5.1B | 2.71% | new | | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 12.8M | $4.5B | 2.37% | +8.1% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-04 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-04 | $4.37 | +64.9% | $10.05B | +9.5% | | 2026-03-31 | 2026-04-30 | $3.34 | +4.4% | $8.62B | +5.8% | | 2025-12-31 | 2026-02-03 | — | — | $9.87B | +8.6% | | 2025-09-30 | 2025-11-04 | $5.93 | +13.6% | $9.56B | +12.4% |
As-reported XBRL · next 2026-11-03 est.ⓘ Segment mixFY2025 (ended Dec 2025) US 72% · Non Us 28% geographic · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
